Volume | 402,774 |
|
|||||
News | - | ||||||
Day High | 9.4299 | Low High |
|||||
Day Low | 9.15 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.30 | 9.15 | 9.4299 | 9.35 | 9.17 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,912 | 402,774 | US$ 9.28 | US$ 3,738,401 | - | 8.93 - 28.42 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 99,828 | US$ 9.35 | USD |
Nevro (NVRO) Options Flow Summary
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
340.32M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.44 | 9.56 | 9.13 | 9.30 | 565,771 | -0.09 | -0.95% |
1 Month | 11.45 | 11.79 | 8.93 | 10.21 | 592,982 | -2.10 | -18.34% |
3 Months | 15.13 | 15.98 | 8.93 | 11.80 | 526,551 | -5.78 | -38.20% |
6 Months | 16.93 | 22.64 | 8.93 | 15.46 | 551,239 | -7.58 | -44.77% |
1 Year | 26.60 | 28.42 | 8.93 | 17.93 | 548,300 | -17.25 | -64.85% |
3 Years | 150.00 | 182.45 | 8.93 | 50.95 | 552,560 | -140.65 | -93.77% |
5 Years | 58.64 | 188.14 | 8.93 | 74.60 | 491,211 | -49.29 | -84.06% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |